You are here: Industry Insights > AstraZeneca

News List

Benefits of AZ vaccine outweigh risks, says MHRA pharmatimes
April 08, 2021
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has concluded that there is a possible link between AstraZeneca's COVID-19 vaccine and “extremely rare, unlikely to occur blood clots”.
US gives charge of facility that botched COVID vaccine to J&J, stops AstraZeneca from using the plant expresspharma
April 06, 2021
AstraZeneca, whose vaccine has not been approved in the US, said it will work with President Joe Biden’s administration to find an alternative site to produce its vaccine.
AstraZeneca Releases Statement on COVID-19 Vaccine Supply at Anagni Plant in Italy americanpharmaceuticalreview
April 02, 2021
The following is a statement from AstraZeneca regarding the company’s vaccine supply at their Anagni Plant in Italy.
EU asks India for 10 million AstraZeneca vaccines to meet shortfall expresspharma
April 02, 2021
Any quick approval of the EU request is unlikely, however, with India scrambling to expand its own domestic vaccination drive, said a Indian government official.
Canada's National Advisory Committee on Immunization Issues Warning Against AstraZeneca COVID-19 Vaccine americanpharmaceuticalreview
April 01, 2021
Canada's National Advisory Committee on Immunization has recommended the AstraZeneca Covid-19 vaccine should not be used in adults under age 55 while rare cases of serious blood clots following vaccination are being investigated, according to a ...
Increase in vaccine manufacturing capacity and supply for COVID-19 vaccines from AstraZeneca, BioNTech/Pfizer and Moderna worldpharmanews
March 31, 2021
EMA's human medicines committee (CHMP) has adopted several important recommendations that will increase manufacturing capacity and supply of COVID-19 vaccines in the EU.
AstraZeneca, Aji Bio-Pharma Expand Mfg. Agreement contractpharma
March 31, 2021
Ajinomoto Bio-Pharma Services, a provider of biopharmaceutical contract development and manufacturing services, entered an expanded manufacturing agreement with AstraZeneca to include drug product manufacturing.
AstraZeneca confirms COVID-19 vaccine efficacy with primary analysis europeanpharmaceuticalreview
March 29, 2021
Following DSMB concerns about the data released regarding the Phase III US trial, AstraZeneca has now confirmed that its vaccine is 76 percent effective against symptomatic COVID-19.
India gives 1.2 million free doses of AstraZeneca COVID-19 vaccine to Bangladesh expresspharma
March 29, 2021
Bangladesh has also signed a deal with the Serum Institute of India for 30 million doses of the AstraZeneca vaccine.
Could viral vector shortages disrupt the COVID-19 vaccine roll-out? europeanpharmaceuticalreview
March 26, 2021
According to GlobalData, AstraZeneca’s and Janssen’s COVID-19 vaccines could be impacted by global viral vector shortages.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 80 81 Next page